Echocardiographic Assessment of Patients with Fabry Disease

Area of Science:

• Cardiology
• Genetics
• Biochemistry

Background:

• Fabry disease is an X-linked lysosomal storage disorder.
• It stems from a deficiency in the enzyme α-galactosidase A.
• Cardiovascular manifestations, particularly increased left ventricular wall thickness, are common.

Purpose of the Study:

• To provide a comprehensive overview of echocardiographic findings in Fabry disease.
• To highlight structural and functional cardiac abnormalities.
• To identify areas for future research in Fabry cardiomyopathy.

Main Methods:

• Review of existing literature on echocardiography in Fabry disease.
• Analysis of conventional and novel echocardiographic techniques.
• Synthesis of reported structural and functional cardiac abnormalities.

Main Results:

• Echocardiography is a key noninvasive tool for assessing cardiac involvement.
• Various structural and functional abnormalities beyond left ventricular hypertrophy are observed.
• Earlier and more precise characterization can improve patient outcomes.

Conclusions:

• Echocardiography plays a crucial role in diagnosing and monitoring Fabry cardiomyopathy.
• Further research using advanced echocardiographic techniques is warranted.
• Improved characterization may lead to earlier diagnosis, prognostication, and treatment.